did fda ban tirzepatide on Compounded GLP-1 Drugs: What to Know FDA Bans Compounded Tirzepatide! What

The DREAMS-3 data showing superiority over semaglutide for the dual endpoint of glycemic control and weight loss makes mazdutide particularly attractive for the diabetes population

Breastfeeding Wegovy and Mounjaro arent recommended during breastfeeding, because it isnt known whether they pass into breast milk

Some users worry they might be pregnant, others wonder whether its a side effect of rapid weight loss or lower food intake

This means it is exempt from the standard 3-1-1 liquid restriction (3.4 ounces per container, one quart-sized bag)

That transition is not zero-cost: it requires patient communication, prescriber engagement, specialty pharmacy coordination, and monitoring for non-medical switching adverse outcomes